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IL-2 potentiates both growth and cytotoxic function ofT lymphocytes andNK
cells. Resting peripheral blood NK cells can respond directly to rIL-2, without
requirement for accessory cells or cofactors, and enhanced cytotoxicity can be
measured within 4 h after exposure to this lymphokine (1-3) . The majority of
NK cells enter the cell cycle after exposure to IL-2 ; however, only a minor pro-
portion sustain continued growth after this initial response (4) . By contrast,
most resting peripheral blood T cells do not respond directly to IL-2, but
require additional signals (e.g ., IL-1 or activators of protein kinase C) to induce
proliferation (4-6). A subset of low buoyant density T cells, isolated by Percoll
gradient centrifugation, can respond directly to IL-2 (4), presumably since these
T cells are in a "primed" state and require only IL-2 for proliferation .
Activation and proliferation of T cells is accompanied by the de novo expres-
sion of new antigens on the plasma membrane (7-13) . With respect to NK cells,
activation by IL-2, or in mixed lymphocyte cultures, induces the expression of
transferrin receptors, HLA-DR and the CD25 IL-2-R (4, 14-16) . However,
whereas IL-2-induced augmentation of NK cell-mediated cytotoxicity can be
detected within 4 h and is maximal by 18 h after activation, HLA-DR and CD25
are not detectable on the majority ofNK cells during this time period (2-4, 16) .
Thus, there is no direct correlation between the expression of these activation
antigens and lytic activity . In this study, we describe an activation antigen, Leu-
23, that is rapidly induced and phosphorylated after IL-2 stimulation of NK cells
and a subset of low buoyant densityT lymphocytes . Induction of this glycopro-
tein on NK cells is IL-2 dependent and closely parallels the acquisition of lytic
activity .
Materials and Methods
Cells . Mononuclear cells from normal peripheral blood (Stanford Blood Center,
Stanford, CA) were isolated using Ficoll/Hypaque . After plastic adherence and passage
through nylon wool to remove monocytes and B cells, respectively, lymphocytes were
fractionated by centrifugation on discontinuous gradients consisting of 30 and 40% Per-
coll (Pharmacia Fine Chemicals, Piscataway, NJ) in PBS (0.01 M phosphate, 150 mM
NaCI, pH 7.3) containing 10% serum (17) . Low buoyant density and high buoyant den-
sity lymphocytes were isolated from the interface and bottom of the Percoll gradients,
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respectively. Normal thymocytes were obtained from children undergoing cardiac
surgery.
Culture.
￿
Lymphocytes and thymocytes were cultured in RPMI 1640 medium (M.A.
Bioproducts, Walkersville, MD) containing 1 mM glutamine (Gibco Laboratories, Grand
Island, NY), 100 Ag/ml gentamicin (Gibco Laboratories) and either FCS (KC Biological,
Inc., Lenex, KS) or heat-inactivated horse serum (KC Biological, Inc.). Lymphocytes were
activated and cultured using rIL-2 (Cetus Corp., Emeryville, CA). In experiments to
establish conditions necessary for the induction of activation antigens, serum-free HB101
medium (Hana Biologicals, Alameda, CA) was used to exclude potential nonspecific stim-
ulation by heterologous serum.
Antibodies. Leu series mAbs were produced by the Becton Dickinson Monoclonal
Center, Inc., Mountain View, CA. Anti-Leu-23 is an IgGI mAB secreted by the L78
hybridoma cell line. L78 hybridoma was generated by immunizing BALB/c mice with a
CD8+ alloantigen-directed CTL cell line. Immune lymph node cells were fused with SP2/
0 Ag14 myeloma cells, and hybridomas were selected in azaserine (18). Rabbit anti-IL-2
serum was purchased from Genzyme, Boston, MA. Goat anti-IL-2 serum (16) was gen-
erously provided by Dr. Giorgio Trinchieri, Wistar Institute, Philadelphia, PA.
Immunofluorescence and Flow Cytometry.
￿
Methods of immunofluorescence, flow cytom-
etry, and data analysis have been described previously (19). Fluorescence was measured
by usinga FACS 440 and data were analyzed by using a Consort 40 Data Analysis System
(Becton Dickinson Immunocytometry Systems).
Cytotoxic Assay.
￿
"'Cr-labeled tumor cells were used as targets in a 4-h radioisotope
release assay (20) .
Immunoprecipitation and Electrophoresis.
￿
Cells were labeled with '25I (Amersham Corp.
Airlington Heights, IL) by using the glucose oxidase/lactoperoxidase method (21). Cells
were solubilized in lysis buffer (50 mM Tris-HCI, 150 mM NaCl, 0.02% sodium azide,
pH 8.0) containing 5 mM 3[3-cholamidopropyl-dimethylammonio]-1-propane sulfonate
(CHAPS)' detergent, 20 KI U/ml aprotinin (Sigma Chemical Co., St. Louis, MO) and 1
mM PMSF (Sigma Chemical Co.). Unincorporated '251 was removed using Dowex 1X8-
400 ion exchange resin (Sigma Chemical Co.), and lysates were precleared by incubation
with formalin-fixed Staphylococcus aureus (Pansorbin; Calbiochem-Behring Corp., San
Diego, CA) coated with rabbit anti-mouse Ig serum (Pel-Freeze Biologicals, Rogers,*AR)
(22). Immunoprecipitation was performed using rabbit anti-mouse Ig-coated S. aureus,
as described (22). Sampleswere analyzed by SDS-PAGE (23), two-dimensional "diagonal"
(1st dimension nonreducing; 2nd dimension, reducing) (24), and two-dimensional non-
equilibrium pH gradient electrophoresis (NEPHGE) using 3.5-10% ampholines (LKB
Instruments, Inc., Gaithersburg, MD) (25).
Deglycosylation.
￿
Antigen was eluted by adding 20 A1 of phosphate buffer (0.1 M, pH
6.1) containing 50 mM EDTA, 1% 2-ME, and I% SDS to the S. aureus/immune complex.
After incubation at 56°C for 20 min, the S. aureus was pelleted by centrifugation at
13,000 g for 15 s. The eluate was removed and diluted 10-fold in phosphate buffer (0 .1
M, pH 6.1) containing 50 mM EDTA and 1 .0% NP-40. Aliquots of equal volume (25 Al)
were placed into microfuge tubes. Endo F (New England Nuclear, Boston, MA) was
added to a final concentration of 23 U/ml, and samples were incubated for 16 h at 37°C.
An equal volume (25 Al) of 2X sample buffer containing 10% 2-ME was added to each
sample to quench the digestion and samples were incubated in a boiling water bath for
5 min. Samples were analyzed by SDS-PAGE and NEPHGE.
Phosphorylation.
￿
Cells were washed and incubated for 1 h at 37°C in phosphate-free
buffer (modified MEM phosphate-free Earle's salts with 25 mM Hepes (Irvine Scientific,
Santa Ana, CA) supplemented with 1 mM glutamine, nonessential amino acids, 100 tag/
ml gentamicin, and 2% heat-inactivated horse serum [dialyzed against modified MEM
phosphate-free Earle's salts]). Cells were resuspended in phosphate-free buffer at 5 X
107 cells/ml containing 1.25 mCi/ml [32p]orthophosphate (carrier-free; Amersham
'Abbreviations used in this paper. CHAPS, 3[3-cholamidopropyl-dimethylammonio]-1-propane sulfo-
nate ; NEPHGE, nonequilibrium pH gradient electrophoresis; PE, phycoerythrin.1574
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Corp.) and 800 U/ml rIL-2. Cells were incubated for 3 h at 37°C, and then washed three
times in cold PBS containing 0.1 mM Na3VO4, 0.4 mM EDTA, 10 mM Na4P10,, 10 MM
NaF, and 0.1% NaN3 . Cells were solubilized in 0.5 ml 5 mM CHAPS lysis buffer (50 mM
Tris-HCI, 150 mM NaCl, 0.02% sodium azide, pH 8.0) containing 1 mM PMSF, 10 mM
iodoacetamide, and 10 mM NaF. After incubation at 4°C for 45 min, nuclei were
removed by centrifugation at 13,000 g for 3 min. Lysates were precleared twice by incu-
bation with packed formalin-fixed S. aureus (Pansorbin; Calbiochem-Behring Corp.)
coated with rabbit anti-mouse Ig serum (Pel-Freeze Biologicals) (22) . Immunoprecipita-
tion was performed using anti-Leu-23 n Ab bound to rabbit anti-mouse Ig-coated S.
aureus, as described (22). After immunoprecipitation, samples were transferred to fresh
microfuge tubes and antigen was eluted using sample buffer containing 2.3% SDS.
Immunoprecipitates were analyzed by two-dimensional "diagonal" gel electrophoresis
(24). After second-dimension electrophoresis, gels were stained in 0 .1% Coomassie Blue
R-250, 50% methanol, 7.5% acetic acid for 20- min, and then incubated overnight at
room temperature in 50 mM NaH2P04;'`10% TCA solution. Gels were subsequently de-
stained twice for 20 min in 5% methanol, 7.5% acetic acid solution, and finally washed
for 20 min in distilled water containing 5% glycerol. Gels were dried and autoradio-
graphed at -70°C on Kodak XR film using intensifying screens (Cronex Lightening Plus;
DuPont Co., Wilmington, DE).
Results
Expression of Leu-23 on IL-2-activated Lymphocytes.
￿
Anti-Leu-23 specifically
reacted with essentially all IL-2-activated NK cells, but reacted only weakly with
a minor proportion of resting peripheral blood NK cells (Table I). Similarly,
anti-Leu-23 was negative or reacted only weakly with most resting peripheral
blood T and B lymphocytes. However, expression of Leu-23 antigen is not
restricted to activated NK cells. As summarized in Table I, Leu-23 is also present
TABLE I
Cellular Distribution of Leu-23
Cell type
Normal peripheral blood
T lymphocytes (CD3+)
B lymphocytes (CD19+)
NK lymphocytes (CD16')
Monocytes
Granulocytes
Normal thymocytes
Normal splenocytes
Normal bone marrow
IL-2-dependent cell lines
CD8 + alloantigen-directed CTL cell
lines
CD4+ tetanus toxoid helper T clones
Thymocyte cell lines
NK cell lines
PHA-activated T lymphoblasts (3 d)
Reactivity
0-5% positive*
0-5% positive*
0-15% positive*
Weakly positive*
<5% positive
^-30% positive
^-10% positive
^-10%
4/4 positivel
5/5 positive,
4/4 positive"
5/5 positive.
^-50% positive
Binding was assessed by direct or indirect immunofluorescence using
flow cytometric analysis.
Based on analysis of 10 normal, adult blood donors.
" Indicates that at least 50% of cells within the cell line expressed detect-
able amounts of Leu-23 antigen.LANIER ET AL.
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on most IL-2-dependent CD8+ CTL cell lines,, CD4 + tetanus-toxoid-specific
helper T cell clones, IL-2-dependent thymocyte cultures, and mitogen-activated
T lymphocytes. The antigen does not simply correlate with proliferation per se,
since it could not be detected on several cultured T leukemia cell lines (HPB-
ALL, PEER, CCRF-CEM) and an EBV-transformed B lymphoblastoid cell line
(CCRF-SB).
Biochemical analysis of the Leu-23 antigen was conducted to determine
whether the different cell types expressing the antigen would demonstrate sim-
ilar structural properties. As shown in Fig. 1 A, an essentially identical structure
was immunoprecipitated from IL-2-dependent cell lines of peripheral blood NK
cells, peripheral blood T lymphocytes, and thymocytes. Anti-Leu-23 immuno-
precipitated a disulfide-bonded 50-60-kD glycoprotein that dissociated into sub-
units of 32 kD and 28 kD after reduction. Two-dimensional "diagonal" SDS-
PAGE analysis confirmed disulfide bonding of the subunits, and the relative
mobility of the subunits below the diagonal suggested that these proteins may
form dimers of 32 + 32 kD, 32 + 28 kD, and 28 + 28 kD proteins (Fig. 1 B).
Deglycosylation of the antigen with a predetermined optimal concentration of
Endo F enzyme revealed a single protein of 24 kD. In experiments to optimize
Endo F digestion conditions, a partially deglycosylated species was observed with
a relative mobility of 28 kD. Since Endo F cleaves both high mannose and com-
plex types of carbohydrates linked through asparagine to the peptide, the Leu-
23 antigen is apparently a protein of 24 kD with at least two sites for N-linked
glycosylation. Two-dimensional NEPHGE analysis of the intact and deglycosy-
lated Leu-23 antigen further indicated that the 32- and 28-kD subunits likely
represent the same polypeptide that differs by the addition of a single N-linked
carbohydrate (Fig. 2 B). The deglycosylated 24-kD protein was resistant to fur-
ther digestion with N-glycanase, an enzyme that hydrolyzes asparagine-linked oli-
gosaccharides that may be resistant to Endo F treatment (not shown). The
microheterogeneity observed in the deglycosylated 24-kD protein may have
resulted from carbamylation of the protein by urea during NEPHGE analysis,
or alternatively could be due to the presence of enzyme-resistant carbohydrates
or O-linked oligosaccharides.
Induction of Leu-23 Antigen.
￿
Experiments were conducted to determine the
conditions necessary to induce expression of Leu-23 on NK cells and T lympho-
cytes. Peripheral blood lymphocytes were separated into low buoyant density
and high buoyant density fractions using Percoll gradient centrifugation. As pre-
viously reported (17), the high buoyant density cells were >95% small, resting
T lymphocytes and the low buoyant density fraction contained both NK cells and
T lymphocytes. Lymphocytes were cultured in 500 U/ml IL-2 and aliquots were
removed after 2, 6, and 18 h of culture. Cells were stained by two-color immu-
nofluorescence with phycoerythrin-(PE)-conjugated anti-Leu-23 and either
FITC-conjugated anti-Leu-11 (CD16) to identify NK cells or FITC-conjugated
anti-Leu 4 (CD3) to identify T lymphocytes. Before stimulation with IL-2, Leu-
23 was not detectable on low buoyant density (large) T cells or high buoyant
density (small) T cells, and was presently only in low amounts on a minor pro-
portion of NK cells (Fig. 3) . However, Leu-23 was detected by 6 h after IL-2
stimulation on the majority of NK cells and a subset of the T lymphocytes in the1576
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low buoyant density fraction . Within 18 h, essentially all IL-2-stimulated NK
cells expressed Leu-23 . By contrast, only a minor proportion of IL-2-stimulated
NK cells expressed transferrin receptors, HLA-DR or CD25 (Fig. 4) . Since all
NK cells expressed Leu-23 within 18 h after exposure to IL-2, this indicates that
FIGURE 1 .
￿
Immunoprecipitation of Leu-23 . (A) IL-2-dependent lines of NK cells, thymo-
cytes (Thy), and peripheral blood T lymphocytes were radiolabeled with 1Z5í and were deter-
gent solubilized. Lysates were immunoprecipitated using S . aureus coated with control immu-
noglobulin or anti-Leu 23 . Immune complexes were eluted in sample buffer containing 2.3%
SDS with or without 5% 2-ME. Samples were analyzed using 10% acrylamide gels . (B) An
aliquot of the anti-Leu-23 immunoprecipitate of IL-2-cultured thymocytes shown in A was
analyzed by two-dimensional "diagonal" SDS-PAGE (1st dimension, nonreducing (NR), 7.5%
acrylamide gels ; 2nd dimension, reducing (R), 10% acrylamide gels) .FIGURE 2 .
￿
Deglycosylation of Leu-23 . (A) An aliquot of the anti-Leu-23 immunoprecipitate
of IL-2-cultured thymocytes shown in Fig. I A was de-glycosylated usingEndo Fand analyzed
by SDS-PAGE (A) and two-dimensional NEPHGE (B) using 10% acrylamide gel. (-) No Endo
F digestion ; (+) Endo F .
all NK cells are IL-2 responsive . NK cells maintained in culture with IL-2 for
72 h remained uniformly Leu-23+ (not shown) . Whereas all NK cells acquired
Leu-23, even after 72 h of culture with IL-2 only a subset of theT lymphocytes
in the low buoyant density fraction expressed this antigen (not shown) . In con-
trast to the T lymphocytes in the low buoyant density fraction, IL-2 did not
induce Leu-23 expression on a substantial proportion of the small, resting T
NK Cells
￿
LargeT Cells
￿
Small T Cells
Fluorescence (4 Log)
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FIGURE 3 .
￿
Kinetics of induction . Low buoyant density
and high buoyant density peripheral blood lymphocytes
were cultured in serum-free medium in the presence or
absence of 500 U/ml IL-2 . At 0, 2, 6, and 18 h, aliquots
of cells were stained with : FITC-conjugated IgG and PE-
conjugated anti-IgG control antibodies ; FITC-conju-
gated anti-CD16 (Leu 11) and PE-conjugated anti-Leu-
23 ; and FITC-conjugated anti-CD3 (Leu-4) and PE-con-
jugated anti-Leu-23 . Samples were analyzed by flow
cytometry . Electronic gates were set on low buoyant
density CD16+ cells (NK cells), low buoyant density
CD3+ cells (large T cells), and high buoyant density
CD3+ cells (small T cells) and data were reprocessed to
determine the amount of Leu-23 antigen expression on
each population . Histograms of anti-Leu-23-stained
cells are superimposed over the histograms of cells
stained with the IgGI control antibody. The control is
the histogram nearest the ordinate in each plot .1578
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A Leu-23
C HLA-DR
￿
. D CD25
A -IL-2
￿
B +IL-2
Fluorescence (4 Log)
￿
Fluorescence (4 Log)
lymphocytes in the high buoyant density fraction (Fig. 3), even after 72 h of
culture (not shown) .
Induction of Leu-23 antigen by IL-2 was dose dependent (Fig . 5) . After 18 h
of culture, low levels of Leu-23 antigen were induced on NK cells at 3 U/ml IL-
2, and 100 U/ml IL-2 was sufficient for induction of the antigen on a majority
ofNK cells . IL-2 was necessary and sufficient to induce expression of Leu-23
on NK cells . As shown in Fig . 6., NK cells, purified by isolating CD16+ lympho-
cytes from the low buoyant density fraction using a FACS, acquired expression
Fluorescence (4 Log)
￿
Fluorescence (4 Log)
Fluorescence (4 Log)
￿
Fluorescence (4 Log)
FIGURE 4 . Activation antigens expressed on IL-2-
stimulated NK cells . Low buoyant density peripheral
blood lymphocytes were cultured in serum-free
medium in the presence or absence of 500 U/ml II:
2 . After 18 h, cells were stained with : FITC-conju-
gated IgG and PE-conjugated IgG control antibod-
ies; FITC-conjugated anti-Leu-23 (A) and PE-conju-
gated anti-CD16 (Leu-11), FITC-conjugated anti-
transferrin receptor (B) and PE-conjugated anti-
CD16 (Leu-11) ; FITC-conjugated anti-CD16 (Leu-
11) and PE-conjugated anti-HLA-DR (C) ; and FITC-
conjugated anti-CD16 (Leu-11) and PE-conjugated
anti-CD25 (IL-2-R) (D) . Cells were analyzed by flow
cytometry . An electronic gate was placed on CD16'
NK cells and data were reprocessed to determine the
amount of each activation antigen coexpressed on
NK cells . Data are presented as described in Fig . 3 .
FIGURE 5 .
￿
IL-2 Concentration required for induction .
Low buoyant density peripheral blood lymphocytes were
cultured in serum-free medium in the presence or
absence of the indicated concentration of IL-2 . After 18
h, cells were stained with: FITC-conjugated IgG and PE-
conjugated IgG control antibodies ; and FITC-conju-
gated anti-CDI6 (Leu-11) and PE-conjugated anti-Leu-
23 . Cells were analyzed by flow cytometry . An electronic
gate was placed on CD16+ NK cells and data were
reprocessed to determine the amount of Leu-23 antigen
coexpressed on NK cells . Data are presented as
described in Fig. 3 .
FIGURE 6 .
￿
Induction of Leu-23 on purified NK cells .
Low buoyant density peripheral blood lymphocytes were
stained with FITC-conjugated anti-CD16 (Leu-11) and
CD16+ NK cells were isolated to >95% purity using a
FACS . NK cells were cultured in serum-free medium in
the presence or absence of the indicated concentration
of IL-2 . After 18 h, cells were stained with : PE-conju-
gated Ig control antibody and PE-conjugated anti-Leu
23 . Cells were analyzed by flow cytometry. Data are pre-
sented as described in Fig . 3 .LANIER ET AL.
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of Leu-23 after 18 h of culture with IL-2 . T lymphocytes, monocytes, or other
accessory cells were not required for IL-2 to induce the expression of Leu-23
on NK cells.
Correlation ofLeu-23 Antigen and IL-2-induced Cytotoxicity.
￿
We have previously
demonstrated that NK cells can lyse NK-resistant tumor cell targets, including
autologous tumors, after activation by IL-2 (3). The kinetics and dose require-
ments for IL-2-enhanced cytotoxicity are quite similar to those required for the
induction of Leu-23 antigen (2, 3). Thus, further studies were conducted to
determine whether IL-2 enhancement of cytotoxicity would correlate with
expression of Leu-23. In these experiments, low buoyant density cells were cul-
tured with 100 U/ml IL-2 for 18 h in the presence or absence of neutralizing
anti-IL-2 serum. As shown in Table II, both IL-2-enhanced cytotoxicity against
a colon carcinoma cell line and induction of Leu-23 on NK cells were compar-
ably inhibited by the neutralizing antiserum. Note the quantitative relationship
between inhibition of cytotoxicity and inhibition of Leu-23 antigen induction.
These results demonstrate that both phenomena are IL-2 dependent, and pos-
sibly, coregulated events .
Experiments were performed to determine whether or not the level of Leu-
23 antigen expression would correlate with lytic activity. Low buoyant density
cells were cultured with 6 and 12 U/ml for 18 h, and were then stained with
FITC-conjugated anti-CD16 and PE anti-Leu-23. As shown in Fig. 3, low levels
of Leu-23 were induced on the CD16+ NK cell population under these condi-
tions. Although no distinct negative or positive subsets of Leu-23 were evident,
it was possible to identify CD16+ NK cells that were negative or expressed low
amounts of Leu-23 antigen and CD16+ NK cells that expressed relatively high
levels of Leu-23 antigen. Leu-23 negative (or "dim" positive) and Leu 23
TABLE II
IL-2 Induction ofLeu-23 and Cytotoxicity
Low buoyantdensity peripheral blood lymphocytes were cultured in serum-free medium in the pres-
ence or absenceof 100 U/ml IL-2 with or without normal rabbit serum (1/100 dilution), rabbit anti-
IL-2 (1/100 dilution), or goat anti-IL-2 (1/100 dilution).Goat anti-IL-2 serumwas used at adilution
determined to completely neutralize 100 U/ml IL-2. Rabbit anti-IL-2 was used at a concentration to
achieve 50% inhibition of 100 U/ml IL-2. After 18 h of culture, cells were harvestedand assayed for
cytotoxicity against "Cr-labeled K562 and Colo-205 tumorcell targets at an effector/targetratio of
12 :1 . Cells were also stained with FITC-conjugated IgG control antibody or FITC-conjugated anti-
Leu-23 and were analyzed by flow cytometry. Percent inhibition of Leu-23 antigen was determined
by comparison of the mean fluorescence of cells cultured with IL-2 in the presence or absence of
neutralizing antiserum.
Antiserum IL-2
K562
Cytotoxicity
Colo-205
Inhibition
of Colo-
205 lysis
Inhibition of
Leu-23 antigen
None - 43 0
None + 97 60
Normal serum + 100 65 0 0
Rabbit anti-IL-2 + 69 20 69 50
Goat anti-IL-2 + 41 0 100 961580
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FIGURE 7 . Cytotoxicity mediated
by NK cells expressing Leu-23 . Low
buoyant density peripheral blood
lymphocytes were cultured in serum-
free medium containing 6 U/ml IL-
2 (A) or 12 U/ml IL-2 (B) . After 18
h, cells were harvested and stained
with FITC anti-Leu-23 and PE anti-
CD16 (Leu-11) . CD16+, Leu-23-
(or dim Leu-23) and CD16+ , Leu-
23+ cells were isolated to >95%
purity using a FACS . Reanalysis of
the sorted fractions is presented.
The histogram of FITC-conjugated
IgG control stained cells is nearest
the ordinate in each plot, whereas
the histograms of Leu-23- or Leu-
23 dim population and Leu-23
bright positive cells are to the right
of the control histogram. Unsorted low buoyant density cells (0), CD16 + , Leu-23 - (or dim) 011),
and CD16+, Leu-23+ (0) cells were assayed for cytotoxicity against "Cr-labeled Colo-205 colon
carcinoma cell targets (x-axis, effector/target ratio ; y = axis, percent cytotoxicity) .
"bright" CD16' NK cells were isolated using a FACS ; reanalysis of the purified
populations is presented in Fig . 7 . Using 6 U/ml IL-2 for induction, no aug-
mentation of cytotoxicity was observed against an NK-insensitive colon carci-
noma cell line, even though low levels of Leu-23 antigen could be detected on
theNK cell population (Fig . 7 A) . These results indicate that Leu-23 antigen can
be expressed before detection of cytotoxic activity . Using 12 U/ml IL-2 for
induction, cytotoxicity was mediated by NK cells that expressed both "dim" and
"bright" levels of Leu-23 antigen (Fig . 7 B) . Comparison of the cytotoxic activity
mediated at several effector/target ratios clearly indicated that NK cells express-
FIGURE 8 .
￿
Phosphorylation of Leu-23 . Low buoyant density peripheral blood lymphocytes
were cultured for 18 h with 800 U/ml IL-2 and were labeled with [32p] orthophosphate dur-
ing the last 3 h of culture . Cells were detergent solubilized and lysates were immunoprecip-
itated with control Ig (A) or anti-Leu-23 (B) . Samples were analyzed two-dimensional "diag-
onal" SDS-PAGE using 10% acrylamide gels for both dimensions (Ist dimension,
nonreducing [NR] ; 2nd dimension, reducing [R]) . After 15 h of culture with IL-2 (immedi-
ately before addition of [12p]orthophosphate), all CD16+ NK cells in the culture expressed
the Leu 23 antigen (-40% of the total cells), and ^-20% of the low buoyant density CD3+
T lymphocytes expressed Leu-23 (not shown) .LANIER ET AL .
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ing higher levels of Leu-23 antigen were more lytic than the population of NK
cells lacking Leu-23 or expressing low levels of this antigen.
IL-2-induced Phosphorylation of Leu-23.
￿
Lymphocyte stimulation results in
activation of intracellular protein kinases, which in turn phosphorylate growth
factor receptors, components of the TCR complex, and certain other membrane
glycoproteins (26-31) . Experiments were conducted to determine whether Leu-
23 is phosphorylated, as well as induced by IL-2 . In these experiments, low
buoyant density lymphocytes were cultured with IL-2 for 20 h and were labeled
with [12p]orthophosphate during the last 3 h of culture. Cells were detergent
solubilized, the Leu-23 glycoprotein was immunoprecipitated, and samples were
analyzed by two-dimensional "diagonal" SDS-PAGE (Fig . 8) . Disulfide-bonded
[32P]-labeled protein dimers composed of 32 and 28 kD subunits were detected,
identical in structure to the 121I-labeled membrane proteins presented in Fig. 1
B. Therefore, the Leu-23 glycoprotein is both induced and phosphorylated as a
consequence of IL-2 stimulation.
Discussion
Peripheral blood NK cells can be activated by IL-2, without requirement for
exogenous cofactors or accessory cells (1-4, 16) . IL-2-induced activation results
both in cellular proliferation and enhancement of NK cytotoxic activity (3, 4) .
Within a few hours after exposure to IL-2, NK cells acquire the capacity to lyse
NK-resistant tumor cell targets, including fresh autologous tumor (1-3, 32, 33) .
Using purified NK effector cells, cytotoxicity is maximal within 18 h after expo-
sure to IL-2 and requires protein synthesis, but not cell division (2, 3) . IL-2 also
induces the expression of certain activation antigens on the plasma membrane
of NK cells ; however, most of these antigens are not detectable until substan-
tially later than detection of IL-2-enhanced cytotoxicity (1, 2, 4, 16). In the pres-
ent study, we have demonstrated that the Leu-23 antigen is detectable on the
surface of NK cells with a few hours after exposure to IL-2 . Previously, it has
been uncertain whether all NK cells or only a subset are responsive to IL-2 .
Since within 18 h after exposure to IL-2, essentially all NK cells express Leu-
23, these findings indicate that all peripheral blood NK cells are responsive to
stimulation by IL-2 . The kinetics of Leu-23 antigen induction closely parallel the
acquisition of cytolytic activity . Both expression of Leu-23 antigen and enhanced
NK cell-mediated cytotoxicity can be induced directly by exposure to IL-2, with-
out requirement for additional activation signals . Moreover, both events were
neutralized by anti-IL-2 antiserum to a comparable extent . These results suggest
that the two events may be coregulated .
The ability of IL-2 to induce Leu-23 antigen on a subset of low buoyant den-
sityT lymphocytes, but not a substantial proportion of small, resting T lympho-
cytes, suggests that this subset of T lymphocytes may be "primed" in vivo,
requiring only IL-2 for activation . Recently, London et al . (4) have reported that
a minor subset of low buoyant density T lymphocytes in peripheral blood enter
the cell cycle after exposure to IL-2 . It should be noted that we have observed
expression of Leu-23 antigen on a small subpopulation of circulating peripheral
blood T and NK lymphocytes in some normal individuals . Whether these cells
represent in vivo activated lymphocytes will be examined in further studies .1582
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It is possible that the Leu-23 glycoprotein is involved in the IL-2 activation of
NK and T lymphocytes. However, we have been unable to directly demonstrate
involvement of the Leu-23 antigen with cell function . Anti-Leu-23 mAb did not
inhibit IL-2-induced NK cell-mediated cytotoxicity or IL-2-induced proliferation
of NK orT lymphocytes (unpublished observations) . It is unlikely that the Leu-
23 glycoprotein is involved directly with the cytolytic process, since the antigen
is also present on noncytotoxic lymphocytes (e .g., CD4+ tetanus-toxoid-specific
T cell clones, mitogen-activated T lymphoblasts, and normal thymocytes) .
Expression of Leu-23 on lymphocytes with diverse immune functions suggests
that this glycoprotein may be involved in more general processes involved with
cellular activation .
Structural features of the antigen are consistent with the possibility that Leu-
23 is a membrane receptor for growth or differentiation factors . Leu-23 is a
disulfide-linked homodimer composed of 24-kD subunits with at least two N-
linked carbohydrates . Of particular interest was the observation that the glyco-
protein is both induced and phosphorylated via an IL-2-dependent process.
Many growth factor receptors, including somatomedin C, epidermal growth fac-
tor receptor, insulin receptor, and IL-2, are phosphorylated subsequent to cel-
lular activation (26-29) . The present studies indicated that for NK cells and a
subset of low buoyant density T cells, IL-2 is the only exogenous factor neces-
sary to induce expression of Leu-23 . Further studies will be necessary to eluci-
date the intracellular events that occur subsequent to IL-2 binding and result in
the induction and phosphorylation of Leu-23 .
The EA-1 (31) and MLR3 (34) activation antigens have structural properties
and a cellular distribution similar to Leu-23 . Whether EA-1, MLR3, and Leu-
23 are the same antigen, distinct epitopes on the same antigen or different gly-
coproteins will require comparative binding and biochemical analysis . Hara et
al . (31) previously demonstrated that the EA-1 antigen is rapidly induced on T
lymphocytes after activation by mitogens or antigens and that the glycoprotein
is phosphorylated after stimulation with phorbol ester ; however, in these exper-
iments the role of IL-2 in the process was not investigated . Similarly, expression
of MLR-3 is rapidly induced by mitogen activation ofT lymphocytes (34) . Cosu-
lich et al . (34) have reported that mAb against MLR3 inhibits IL-1-dependent
stimulation of resting T cells using anti-CD3 . Although we have not determined
the functional effect of anti-Leu-23 mAb on IL-1-dependent T cell activation,
IL-1 did not affect expression of Leu-23 antigen on NK cells (unpublished
observation) .
In conclusion, the Leu-23 antigen is rapidly induced on peripheral blood NK
cells and a unique subset of T lymphocytes after exposure to IL-2, without the
requirement for exogenous cofactors or accessory cells. The kinetics of IL-2-
induced expression of Leu-23 on NK cells closely paralleled the acquisition of
cytotoxic function against solid tumor cell targets, thereby providing a useful
marker of NK cell activation . The rapid induction and phosphorylation of this
glycoprotein suggest that the structure may be involved in IL-2-dependent acti-
vation mechanisms . Further studies directed at defining the molecular proper-
ties of this membrane antigen may provide valuable insight into function of this
glycoprotein .Summary
IL-2 potentiates both growth and cytotoxic function of T lymphocytes and NK
cells . Resting peripheral blood NK cells can respond directly to rIL-2, without
requirement for accessory cells or cofactors, and enhanced cytotoxicity can be
measured within a few hours after exposure to this lymphokine . In this study,
we describe an activation antigen, Leu-23, that is rapidly induced and phospho-
rylated after IL-2 stimulation of NK cells and a subset of low buoyant density T
lymphocytes . Previously, it has been uncertain whether all NK cells or only a
subset are responsive to IL-2 . Since within 18 h after exposure to IL-2, essen-
tially all NK cells express Leu-23, these findings indicate that all peripheral
blood NK cells are responsive to stimulation by IL-2 . The Leu-23 antigen is a
disulfide-bonded homodimer, composed of 24-kD protein subunits with two N-
linked oligosaccharides . Appearance of this glycoprotein on NK cells is IL-2
dependent and closely parallels IL-2-induced cytotoxicity against NK-resistant
solid tumor cell targets .
We thank Dr . Jim Allison for invaluable discussion and advise relating to the phosphor-
ylation experiments ; Drs . Brett Gemlo and Anthony Rayner for providing thymocytes ;
and Dr . Anne Jackson for providing the phycoerythrin-conjugated anti-Leu-23 reagent.
Received for publication 2 December 1987.
LANIER ET AL.
￿
1583
References
1 . Trinchieri, G ., M . Matsumoto-Kobayashi, S . C . Clark, J . Seehra, L . London, and B .
Perussia. 1984 . Response of resting human peripheral blood natural killer cells to
interleukin 2 .J. Exp. Med. 160:1147 .
2 . Lanier, L . L ., C. J . Benike, J . H . Phillips, and E . G . Engleman . 1985 . Recombinant
interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte
subpopulations expressing the Leu 7 and Leu I 1 antigens .J. Immunol . 134:794 .
3 . Phillips, J . H ., and L. L . Lanier . 1987 . Dissection of the lymphokine-activated killer
phenomenon . Relative contribution of peripheral blood natural killer cells and T
lymphocytes to cytolysis . J. Exp . Med . 164:814 .
4 . London, L., B . Perussia, and G . Trinchieri . 1986 . Induction of proliferation in vitro
of resting human natural killer cells : IL 2 induces into cell cycle most peripheral
blood NK cells, but only a minor subset of low density T cells . J. Immunol. 137:3845 .
5 . Manger, B ., A . Weiss, C . Weyand, J . Gornozy, and J . D . Stobo . 1985 . T cell activa-
tion : differences in the signals required for IL 2 production by nonactivated and
activated T cells . J. Immunol. 135:3669 .
6 . Mizel, S . B . 1982 . Interleukin 1 and T cell activation . Immunol . Rev. 63 :51 .
7 . Cotner, T., J . M . Williams, L . Christenson, H . M . Shapiro, T. B . Strom, and J .
Strominger . 1983 . Simultaneous flow cytometric analysis ofhuman T cell activation
antigen expression and DNA content .J. Exp. Med. 157 :461 .
8 . Maino, V ., and M . E . Janszen . 1986 . Monoclonal antibodies, L-35 and L-36, define
novel T cell activation antigens .J. Immunol . 137:3093 .
9 . Uchiyama, T ., S . Broder, and T . A . Waldmann . 1981 . A monoclonal antibody (Anti-
Tac) reactive with activated and functionally mature human T cells . I . Production of
anti-Tac monoclonal antibody and distribution of Tac (+) cells . J. Immunol.
126:1393 .
10 . Haynes, B . F ., M . E . Hemler, D . L . Mann, G . S . Eisenbarth, J . Shelhamer, H . S .1584
￿
INTERLEUKIN 2-INDUCED ACTIVATION ANTIGEN
Mostowski, C . A . Thomas, J . L . Strominger, and A . S . Fauci . 1981 . Characterization
of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of
activated lymphocytes . J. Immunol. 126:1409 .
11 . Evans, R. L ., T . J . Faldetta, R. E . Humphreys, D . M . Pratt, E . J . Yunis, and S . F .
Schlossman . 1978 . Peripheral human T cells sensitized in mixed leukocyte culture
synthesize and express Ia-like antigens . J. Exp . Med. 148:1440 .
12 . Omary, M . B., I . S . Trowbridge, and J . M . Minowada. 1980 . Human cell-surface
glycoprotein with unusual properties . Nature (Lond.). 286 :888 .
13 . Hemler, M . E ., J . Jacobson, M . B . Brenner, D . Mann, and J . L . Strominger . 1985 .
VLA-1 : a T cell surface antigen which defines a novel late stage of human T cell
activation . Eur. J. Immunol . 15:502 .
14 . Phillips, J . H ., A. M . Le, and L . L . Lanier . 1984 . Natural killer cells activated in a
human mixed lymphocyte response culture identified by expression of Leu-11 and
class II histocompatibility antigens . J. Exp . Med . 159:993 .
15 . Phillips, J . H ., and L . L . Lanier. 1985 . A model for the differentiation of human
natural killer cells. Studies on the in vitro activation of Len 11+ granular lympho-
cytes with a natural killer-sensitive tumor cell, K562 . J. Exp. Med. 161 :1464 .
16 . London, L ., B . Perussia, and G . Trinchieri . 1985 . Induction of proliferation in vitro
of resting human natural killer cells: expression of surface activation antigens . J.
Immunol. 134:718 .
17 . Phillips, J . H ., N . L . Warner, and L . L . Lanier . 1984 . Correlation of biophysical
properties and cell surface antigenic profile of Percoll gradient-separated human
natural killer cells . Nat. Immun . Cell Growth Regul . 3:73 .
18 . Foung, S . K . H ., D . T . Sasaki, C . F . Grumet, and E . G . Engleman . 1982 . Production
of functional T-T hybridomas in selection medium lacking aminopterin and thymi-
dine . Proc . Natl . Acad. Sci. USA . 79 :7484 .
19 . Parks, D . R ., L . L . Lanier, and L . A . Herzenberg . 1986 . Flow cytometry and fluo-
rescence activated cell sorting (FACS) . In Handbook of Experimental Immunology.
Fourth ed ., D . M . Weir, L . A . Herzenberg, C . C . Blackwell, and L. A . Herzenberg,
editors . Blackwell Publications, Ltd., Oxford, United Kingdom . 29 .1-29 .21 .
20 . Lanier, L . L ., A. M . Le, J . H . Phillips, N . L. Warner, and G . F . Babcock. 1983 .
Subpopulation s of human natural killer cells defined by expression of the Leu-7
(HNK-1) and Leu 11 (NK-15) antigens . J. Immunol. 131 :1789 .
21 . Keski-Oja, J ., D . F . Mosher, and A . Vaheri . 1977 . Dimeric character of fibronectin,
a major cell-surface associated glycoprotein . Biochem. Biophys. Res . Commun. 74:699 .
22 . Lanier, L . L ., N . A . Federspiel, J . J . Ruitenberg, J . H . Phillips, J . P . Allison, D.
Littman, and A . Weiss . 1987 . The T cell antigen receptor complex expressed on
normal peripheral blood CD4 - , CD8- T lymphocytes : a CD3-associated disulfide-
linked y chain heterodimer .J. Exp. Med. 165:1076 .
23 . Laemmli, U. K . 1970 . Cleavage of structural proteins during the assembly of the
head of bacteriophage T4 . Nature (Lond.). 227:680 .
24 . Allison, J . P ., B . W . McIntyre, and D . Bloch . 1982 . Tumor-specific antigen of murine
T lymphoma defined with monoclonal antibody. J. Immunol. 129:2293 .
25 . Jones, P . P . 1980 . Analysis of radiolabeled lymphocyte proteins by one- and two-
dimensional polyacrylamide gel electrophoresis . In Selected Methods in Cellular
Immunology . B . B . Mishell and S. M . Shiigi, editors . Freeman Publications San Fran-
cisco, CA . 398-440 .
26 . Shackelford, D. A ., and I . S . Trowbridge . 1984 . Induction of expression and phos-
phorylation of the human interleukin 2 receptor by a phorbol diester .J. Biol . Chem.
259:11706 .LANIER ET AL .
￿
1585
27 . Hunter, T ., and J . A . Cooper, 1985 . Protein-tyrosine kinases . Annu. Rev. Biochem.
54:897 .
28 . Jacobs, S ., N . E . Sahyoun, A . R . Saltiel, and P . Cuatrecasas . 1983 . Phorbol esters
stimulate the phosphorylation of receptors for insulin and somatomedin C . Proc .
Natl . Acad. Sci . USA . 80:6211 .
29 . Iwashita, S ., and C . R . Fox . 1984 . Epiderma l growth factor and potent phorbol
tumor promoters induce epidermal growth factor receptor phosphorylation in a sim-
ilar by distinctively different manner in human epidermoid carcinoma A431 cells . J.
Biol . Chem . 259:2559 .
30 . Samelson, L . E., J . B . Harford, and R . D . Klausner . 1985 . Identification of the com-
ponents of the murine T cell antigen receptor complex . Cell . 43 :223 .
31 . Hara, T ., L . K. L. Jung, J . M . Bjorndahl, and S . M . Fu . 1986 . Human T cell acti-
vation. III . Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early
activation antigen (EA-1) by 12-o-teradecanoyl phorbol-13-acetate, mitogens, and
antigens . J. Exp . Med . 164:1988 .
32 . Itoh, K ., A . B . Tilden, and C . M . Balch . 1986 . Lysis of human solid tumor cells by
lymphokine-activated natural killer cells .J. Immunol . 136:3910 .
33 . Ortaldo, J . R ., A . Mason, and R. Overton . 1986 . Lymphokine-activated killer cells :
analysis of progenitors and effectors . J. Exp . Med. 164:1193 .
34 . Cosulich, M . E ., A . Rubartelli, A . Risso, F . Cozzolino, and A . Bargellesi . 1987 . Func-
tional characterization of an antigen involved in an early step of T-cell activation .
Proc . Natl. Acad. Sci. USA . 84:4205 .